A University of Arizona professor is overseeing the production of an experimental drug that could help reduce brain damage after a stroke. Dr. Thomas Davis, professor of pharmacology in the UA College of Medicine, is directing the manufacture of this treatment for human trials. In his recent study published in the journal Stroke, Dr. Davis found that the drug - 3K3A-APC - was most effective when used in conjunction with a clot-busting therapy known as tissue plasminogen activator.
Related
